Illinois House Bill 4822 (Prior Session Legislation)

---

Spectrum: Partisan Bill (Republican 2-0)
Status: Introduced on February 11 2020 - 25% progression, died in committee
Action: 2020-06-23 - Rule 19(b) / Re-referred to Rules Committee
Pending: House Rules Committee
Text: Latest bill text (Introduced) [HTML]

Creates the Preserving Access to Affordable Drugs Act. Provides that an agreement resolving or settling, on a final or interim basis, a patent infringement claim in connection with the sale of a pharmaceutical product is presumed to have anticompetitive effects and is a violation of the Act if certain circumstances apply. Provides other requirements for patent infringement claims in connection with the sale of a pharmaceutical product. Contains provisions regarding presumptions in an action under the Act. Provides civil penalties for violating the Act. Provides that any penalty shall accrue only to the State of Illinois and shall be recovered in a civil action brought by the Attorney General against any party to an agreement that violates this Act. Requires an action to enforce a cause of action for a violation of the Act to be commenced within 4 years after the cause of action accrued. Contains other provisions.

ACCESS TO AFFORDABLE DRUGS

Rep. Tom Demmer [R]

Rep. Norine Hammond [R]

Date	Chamber	Action
2020-06-23	House	Rule 19(b) / Re-referred to Rules Committee
2020-06-18	House	Added Chief Co-Sponsor Rep. Norine K. Hammond
2020-03-12	House	Assigned to Prescription Drug Affordability & Accessibility Committee
2020-02-18	House	Referred to Rules Committee
2020-02-18	House	First Reading
2020-02-11	House	Filed with the Clerk by Rep. Tom Demmer

Type	Source
Summary	https://www.ilga.gov/legislation/BillStatus.asp?DocNum=4822&GAID=15&DocTypeID=HB&SessionID=108&GA=101
Text	https://www.ilga.gov/legislation/101/HB/10100HB4822.htm